Numis Securities Ltd lowered shares of ConvaTec Group PLC (LON:CTEC) to a sell rating in a research report sent to investors on Monday, October 16th. The firm currently has GBX 220 ($2.90) price target on the stock.
Other research analysts have also recently issued research reports about the stock. Peel Hunt restated a buy rating and issued a GBX 380 ($5.01) price objective on shares of ConvaTec Group PLC in a report on Thursday, August 3rd. Goldman Sachs Group, Inc. (The) restated a buy rating and issued a GBX 340 ($4.49) price objective on shares of ConvaTec Group PLC in a report on Thursday, August 3rd. Deutsche Bank AG lifted their price objective on shares of ConvaTec Group PLC from GBX 330 ($4.35) to GBX 335 ($4.42) and gave the company a buy rating in a report on Monday, August 21st. J P Morgan Chase & Co decreased their price target on shares of ConvaTec Group PLC from GBX 318 ($4.20) to GBX 303 ($4.00) and set an overweight rating for the company in a research note on Friday, August 4th. Finally, Citigroup Inc. reiterated a neutral rating and issued a GBX 290 ($3.83) price target on shares of ConvaTec Group PLC in a research note on Wednesday, October 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of GBX 266.70 ($3.52).
ConvaTec Group PLC (LON CTEC) opened at 207.20 on Monday. The company’s market cap is GBX 4.04 billion. The firm’s 50 day moving average is GBX 258.01 and its 200-day moving average is GBX 292.55. ConvaTec Group PLC has a 52 week low of GBX 191.20 and a 52 week high of GBX 349.10.
COPYRIGHT VIOLATION NOTICE: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/27/convatec-group-plc-ctec-stock-rating-lowered-by-numis-securities-ltd.html.
The business also recently disclosed a dividend, which was paid on Friday, October 20th. Stockholders of record on Thursday, September 7th were given a dividend of GBX 1.06 ($0.01) per share. The ex-dividend date was Thursday, September 7th. This represents a dividend yield of 0.36%.
In related news, insider Christopher Gent acquired 38,889 shares of ConvaTec Group PLC stock in a transaction dated Wednesday, October 18th. The stock was acquired at an average price of GBX 213 ($2.81) per share, for a total transaction of £82,833.57 ($109,307.96).
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.